Thermo Fisher Scientific Income Statement (2009-2026) | TMO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jul2021	Oct2021	Dec2021	Apr2022	Jul2022	Oct2022	Dec2022	Apr2023	Jul2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	9.27B	9.33B	10.70B	11.82B	10.97B	10.68B	11.45B	10.71B	10.69B	10.57B	10.89B	10.35B	10.54B	10.60B	11.39B	10.36B	10.86B	11.12B	12.21B	11.01B
Cost of Revenue (Quarter)	3.35B	0.02B	-4.00B	3.56B	3.52B	2.88B	3.68B	3.23B	3.28B	3.04B	3.73B	3.20B	3.11B	3.10B	3.46B	3.12B	3.21B	3.32B	3.23B	3.26B
Gross Profit (Quarter)	5.92B	9.31B	14.70B	8.26B	7.45B	7.80B	7.77B	7.48B	7.41B	7.53B	7.15B	7.14B	7.43B	7.50B	7.93B	7.24B	7.65B	7.80B	8.98B	7.74B
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)	0.34B	0.35B	0.39B	0.36B	0.36B	0.35B	0.39B	0.35B	0.34B	0.32B	0.33B	0.33B	0.34B	0.35B	0.37B	0.34B	0.35B	0.35B	0.36B	0.34B
Selling, General & Administrative (Quarter)	1.90B	2.00B	2.28B	2.28B	2.21B	2.21B	2.30B	2.12B	2.15B	2.05B	2.13B	2.18B	2.11B	2.10B	2.20B	2.08B	2.14B	2.16B	2.35B	2.18B
Restructuring Costs (Quarter)	0.12B	0.02B	0.05B	0.00B	0.02B	0.03B	0.06B	0.11B	0.18B	0.08B	0.08B	0.03B	0.08B	0.04B	0.23B	0.10B	0.08B	0.14B	0.05B	0.05B
Other Operating Expenses (Quarter)	4.75B	4.68B	5.45B	6.35B	6.37B	6.38B	6.84B	6.57B	6.44B	6.26B	6.49B	6.14B	6.20B	6.27B	6.57B	6.13B	6.45B	6.54B	7.21B	6.58B
Operating Expenses (Quarter)	7.11B	7.05B	8.16B	9.00B	8.97B	8.97B	9.59B	9.15B	9.11B	8.71B	9.03B	8.68B	8.72B	8.76B	9.38B	8.65B	9.02B	9.18B	9.96B	9.14B
Operating Income (Quarter)	2.16B	2.28B	2.54B	2.82B	2.00B	1.71B	1.86B	1.56B	1.58B	1.86B	1.85B	1.66B	1.82B	1.84B	2.02B	1.72B	1.83B	1.94B	2.25B	1.86B
EBIT (Quarter)	2.16B	2.28B	2.54B	2.82B	2.00B	1.71B	1.86B	1.56B	1.58B	1.86B	1.85B	1.66B	1.82B	1.84B	2.02B	1.72B	1.83B	1.94B	2.25B	1.86B
Non-operating items
Interest & Investment Income (Quarter)	0.01B	0.01B	0.01B	0.02B	0.04B	0.07B	0.15B	0.15B	0.18B	0.25B	0.31B	0.28B	0.29B	0.28B	0.23B	0.20B	0.30B	0.23B	0.26B	0.23B
Other Non Operating Income (Quarter)	-0.00B	0.02B	-0.53B	-0.16B	0.03B	-0.00B	0.04B	-0.05B		0.01B	-0.03B	0.01B	0.01B	-0.02B	0.01B	0.00B	-0.02B	-0.00B	0.01B	-0.01B
Non Operating Income (Quarter)	-0.00B	0.02B	-0.53B	-0.16B	0.03B	-0.00B	0.04B	-0.05B		0.01B	-0.03B	0.01B	0.01B	-0.02B	0.01B	0.00B	-0.02B	-0.00B	0.01B	-0.01B
Net income details
EBT (Quarter)	2.05B	2.18B	1.86B	2.54B	1.92B	1.60B	1.78B	1.36B	1.43B	1.76B	1.74B	1.59B	1.76B	1.74B	1.94B	1.62B	1.71B	1.83B	2.15B	1.73B
Tax Provisions (Quarter)	0.22B	0.27B	0.20B	0.30B	0.20B	0.03B	0.17B	0.05B	0.05B	0.05B	0.13B	0.28B	0.13B	0.10B	0.15B	0.10B	0.09B	0.21B	0.15B	0.07B
Profit After Tax (Quarter)	1.83B	1.90B	1.66B	2.22B	1.67B	1.50B	1.57B	1.29B	1.36B	1.70B	1.65B	1.33B	1.55B	1.63B	1.83B	1.51B	1.62B	1.62B	1.97B	1.66B
Equity Income (Quarter)	-0.00B	-0.00B		-0.02B	-0.05B	-0.07B	-0.03B	-0.03B	-0.02B	-0.02B	-0.00B	0.02B	-0.08B	-0.01B	0.03B	-0.01B	0.00B	0.00B	-0.03B	-0.01B
Net Income - Minority (Quarter)			-0.06B	-0.06B	-0.06B	-0.06B	-0.05B	-0.05B	-0.05B	-0.02B	0.01B	0.01B	0.01B	0.02B	0.03B	0.03B	0.04B	-0.01B	-0.01B	-0.01B
Income from Non-Controlling Interests (Quarter)	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	-0.00B	0.00B	0.00B	-0.02B	-0.02B	0.00B	0.01B		-0.01B	0.00B	0.00B	0.01B	0.01B	0.01B
Income from Continuing Operations (Quarter)	1.83B	1.91B	1.66B	2.24B	1.72B	1.57B	1.60B	1.32B	1.38B	1.71B	1.61B	1.31B	1.64B	1.64B	1.79B	1.52B	1.62B	1.62B	2.00B	1.66B
Consolidated Net Income (Quarter)	1.83B	1.91B	1.66B	2.24B	1.72B	1.57B	1.60B	1.32B	1.38B	1.71B	1.61B	1.31B	1.64B	1.64B	1.79B	1.52B	1.62B	1.62B	2.00B	1.66B
Income towards Parent Company (Quarter)	1.83B	1.91B	1.60B	2.18B	1.66B	1.51B	1.55B	1.26B	1.33B	1.69B	1.62B	1.32B	1.65B	1.66B	1.82B	1.56B	1.65B	1.61B	1.99B	1.66B
Net Income towards Common Stockholders (Quarter)	1.83B	1.90B	1.66B	2.21B	1.66B	1.50B	1.58B	1.29B	1.36B	1.72B	1.63B	1.33B	1.55B	1.63B	1.83B	1.51B	1.65B	1.61B	1.99B	1.66B
Additional items
EPS (Basic) (Quarter)	4.65	4.83	4.21	5.66	4.25	3.82	4.03	3.34	3.53	4.44	4.21	3.47	4.05	4.26	4.79	3.99	4.28	4.28	5.22	4.44
EPS (Weighted Average and Diluted) (Quarter)	4.61	4.79	4.17	5.61	4.22	3.79	4.01	3.32	3.51	4.42	4.20	3.46	4.04	4.25	4.78	3.98	4.28	4.27	5.21	4.43
Shares Outstanding (Weighted Average) (Quarter)	0.39B	0.39B	0.39B	0.39B	0.39B	0.39B	0.39B	0.39B	0.39B	0.39B	0.39B	0.38B	0.38B	0.38B	0.38B	0.38B	0.38B	0.38B	0.38B	0.37B
Shares Outstanding (Diluted Average) (Quarter)	0.40B	0.40B	0.40B	0.40B	0.39B	0.40B	0.39B	0.39B	0.39B	0.39B	0.39B	0.38B	0.38B	0.38B	0.38B	0.38B	0.38B	0.38B	0.38B	0.37B
EBITDA (Quarter)	2.16B	2.28B	2.54B	2.82B	2.00B	1.71B	1.86B	1.56B	1.58B	1.86B	1.85B	1.66B	1.82B	1.84B	2.02B	1.72B	1.83B	1.94B	2.25B	1.86B
Interest Expenses (Quarter)	0.12B	0.13B	0.16B	0.14B	0.15B	0.17B	0.27B	0.30B	0.33B	0.36B	0.39B	0.36B	0.35B	0.36B	0.32B	0.30B	0.40B	0.35B	0.36B	0.35B
Tax Rate (Quarter)	10.69%	12.45%	10.90%	11.85%	10.33%	1.94%	9.74%	3.37%	3.64%	3.00%	7.64%	17.68%	7.25%	5.68%	7.73%	5.86%	5.38%	11.34%	7.11%	4.04%

Research Tools

Thermo Fisher Scientific Income Statement (2009-2026) | TMO

Create an account

Sign In

Reset Password